CTXR

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Citius Pharmaceuticals Inc

NASDAQ | CTXR

1.42

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$25.86M

Market Cap

-

P/E Ratio

-4.87

EPS

$5.95

52 Week High

$0.65

52 Week Low

HEALTHCARE

Sector

CTXR Chart

Recent Chart
Price Action

CTXR Technicals

Tags:

CTXR Earnings

Yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit -$210K
Total Revenue $0
Cost Of Revenue $210K
Costof Goods And Services Sold $210K
Operating Income -$42M
Selling General And Administrative $18M
Research And Development $12M
Operating Expenses $42M
Investment Income Net -
Net Interest Income $758K
Interest Income $758K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $210K
Income Before Tax -$39M
Income Tax Expense $576K
Interest And Debt Expense -
Net Income From Continuing Operations -$39M
Comprehensive Income Net Of Tax -
Ebit -$39M
Ebitda -$39M
Net Income -$39M

Revenue & Profitability

Earnings Performance

CTXR Financials

yearly Balance Sheet (As of Sep 30, 2024)

Field Value (USD)
Total Assets $117M
Total Current Assets $14M
Cash And Cash Equivalents At Carrying Value $3.3M
Cash And Short Term Investments $3.3M
Inventory $8.3M
Current Net Receivables -
Total Non Current Assets $102M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $93M
Intangible Assets Excluding Goodwill $93M
Goodwill $9.3M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $2.7M
Other Non Current Assets -
Total Liabilities $43M
Total Current Liabilities $36M
Current Accounts Payable $4.9M
Deferred Revenue -
Current Debt -
Short Term Debt $242K
Total Non Current Liabilities $6.7M
Capital Lease Obligations $263K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $263K
Other Current Liabilities $31M
Other Non Current Liabilities -
Total Shareholder Equity $70M
Treasury Stock -
Retained Earnings -$201M
Common Stock $7.2K
Common Stock Shares Outstanding $12M

yearly Cash Flow (As of Sep 30, 2024)

Field Value (USD)
Operating Cashflow -$28M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $210K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -$2.1M
Profit Loss -
Cashflow From Investment -$5M
Cashflow From Financing $10M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$39M

yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit -$210K
Total Revenue $0
Cost Of Revenue $210K
Costof Goods And Services Sold $210K
Operating Income -$42M
Selling General And Administrative $18M
Research And Development $12M
Operating Expenses $42M
Investment Income Net -
Net Interest Income $758K
Interest Income $758K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $210K
Income Before Tax -$39M
Income Tax Expense $576K
Interest And Debt Expense -
Net Income From Continuing Operations -$39M
Comprehensive Income Net Of Tax -
Ebit -$39M
Ebitda -$39M
Net Income -$39M

CTXR News

CTXR Profile

Citius Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Citius Pharmaceuticals Inc. (CTXR), headquartered in Cranford, New Jersey, is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for critical care environments. The firm is focused on addressing substantial unmet medical needs with a promising pipeline of products aimed at improving patient outcomes in hospital settings. Citius leverages cutting-edge technologies and forms strategic collaborations to position itself as a leader in the critical care sector, contributing to transformative advancements in patient care. With a strong commitment to innovation and a clear strategic vision, Citius presents a compelling investment opportunity in the biopharmaceutical arena for institutional investors.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
KTTA
+61.79%
$1.71
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
INTC
+2.73%
$36.81
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-8.37%
$0.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
F
+0.15%
$13.19
AMD
+3.93%
$214.24
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
TLRY
-19.39%
$0.83
SRM
+53.27%
$10.30
PFE
-0.03%
$25.71
AGNC
+1.53%
$10.56
BAC
+0.97%
$52.99
CCL
-1.12%
$25.43
BIYA
+11.34%
$0.28
SNAP
-0.39%
$7.61
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
CRWV
+4.20%
$74.29
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
NVDA
-1.02%
$178.41
AFMD
-34.94%
$0.18
HBI
-0.45%
$6.59
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
BABA
+0.37%
$157.60
NVTS
+3.86%
$8.34
OSCR
+8.54%
$18.16
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
KSS
+7.49%
$24.10
INHD
-7.00%
$0.20
NVO
+3.50%
$48.71
NAKA
+7.20%
$0.49
KDLY
+7.20%
$0.49
TMC
+7.36%
$5.83
ECDA
-3.66%
$0.53
ASST
+2.65%
$1.16
JBLU
+3.43%
$4.52
SAND
-6.04%
$12.12
CLSK
+11.96%
$15.05
LEN
+0.15%
$131.28
MBOT
+21.80%
$2.29
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
NBIS
+6.53%
$94.69
FCX
+2.62%
$42.15
AUR
+3.31%
$4.05
AMC
+1.76%
$2.30
CIFR
+6.60%
$20.41
BMNR
+6.77%
$33.89
SOLT
+7.29%
$8.97
RZLV
-0.99%
$2.98
PACB
-9.12%
$2.39
TSLG
+3.51%
$9.12
KO
+0.37%
$72.88
C
+1.31%
$102.50
BMY
+0.40%
$49.25
NEHC
+8.33%
$5.07
VICI
+0.27%
$28.83
RKLB
-1.57%
$41.93
KWM
+29.58%
$0.66
GAP
+3.49%
$27.53
CSX
+1.14%
$35.30
DEFT
+20.86%
$1.68
PFSA
+5.19%
$0.16
ZIM
+0.97%
$19.70
ONDS
-3.80%
$7.92
SANA
+14.52%
$4.02
CHR
+3.95%
$0.04
MPW
+2.12%
$5.77
CRCA
+7.60%
$3.68
WFC
+0.54%
$85.56
GOOGL
-0.33%
$318.88
MARA
+6.50%
$11.83
GPUS
+1.14%
$0.33
BBWI
+2.78%
$17.37
GT
+0.23%
$8.44
UPXI
-7.02%
$2.78
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
KTTA
+61.79%
$1.71
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
INTC
+2.73%
$36.81
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-8.37%
$0.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
F
+0.15%
$13.19
AMD
+3.93%
$214.24
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
TLRY
-19.39%
$0.83
SRM
+53.27%
$10.30
PFE
-0.03%
$25.71
AGNC
+1.53%
$10.56
BAC
+0.97%
$52.99
CCL
-1.12%
$25.43
BIYA
+11.34%
$0.28
SNAP
-0.39%
$7.61
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
CRWV
+4.20%
$74.29
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
NVDA
-1.02%
$178.41
AFMD
-34.94%
$0.18
HBI
-0.45%
$6.59
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
BABA
+0.37%
$157.60
NVTS
+3.86%
$8.34
OSCR
+8.54%
$18.16
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
KSS
+7.49%
$24.10
INHD
-7.00%
$0.20
NVO
+3.50%
$48.71
NAKA
+7.20%
$0.49
KDLY
+7.20%
$0.49
TMC
+7.36%
$5.83
ECDA
-3.66%
$0.53
ASST
+2.65%
$1.16
JBLU
+3.43%
$4.52
SAND
-6.04%
$12.12
CLSK
+11.96%
$15.05
LEN
+0.15%
$131.28
MBOT
+21.80%
$2.29
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
NBIS
+6.53%
$94.69
FCX
+2.62%
$42.15
AUR
+3.31%
$4.05
AMC
+1.76%
$2.30
CIFR
+6.60%
$20.41
BMNR
+6.77%
$33.89
SOLT
+7.29%
$8.97
RZLV
-0.99%
$2.98
PACB
-9.12%
$2.39
TSLG
+3.51%
$9.12
KO
+0.37%
$72.88
C
+1.31%
$102.50
BMY
+0.40%
$49.25
NEHC
+8.33%
$5.07
VICI
+0.27%
$28.83
RKLB
-1.57%
$41.93
KWM
+29.58%
$0.66
GAP
+3.49%
$27.53
CSX
+1.14%
$35.30
DEFT
+20.86%
$1.68
PFSA
+5.19%
$0.16
ZIM
+0.97%
$19.70
ONDS
-3.80%
$7.92
SANA
+14.52%
$4.02
CHR
+3.95%
$0.04
MPW
+2.12%
$5.77
CRCA
+7.60%
$3.68
WFC
+0.54%
$85.56
GOOGL
-0.33%
$318.88
MARA
+6.50%
$11.83
GPUS
+1.14%
$0.33
BBWI
+2.78%
$17.37
GT
+0.23%
$8.44
UPXI
-7.02%
$2.78
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.